Role of uric acid in hypertension, renal disease, and metabolic syndrome.

@article{Heinig2006RoleOU,
  title={Role of uric acid in hypertension, renal disease, and metabolic syndrome.},
  author={Marcelo Eduardo Heinig and Richard J. Johnson},
  journal={Cleveland Clinic journal of medicine},
  year={2006},
  volume={73 12},
  pages={
          1059-64
        }
}
Hyperuricemia has long been known to be associated with cardiovascular disease, and it is particularly common in people with hypertension, metabolic syndrome, or kidney disease. Most authorities have viewed elevated uric acid as a secondary phenomenon that is either innocuous or perhaps even beneficial, since uric acid can be an antioxidant. However, recent experiments have challenged this viewpoint. In this paper we argue that uric acid is a true risk factor for cardiovascular disease… 
Hyperuricemia as a Potential Determinant of Metabolic Syndrome
TLDR
The role of uric acid in the development of metabolic syndrome and on the possible pathophysiology is focused on.
Uric acid: a starring role in the intricate scenario of metabolic syndrome with cardio-renal damage?
TLDR
There is no evidence indicating that such therapies, that are not free of risk, may reduce cardiovascular events; so that to manage the prescriptions, larger, prospective, interventional data are needed.
Childhood Hyperuricemia as Risk Factor of Hypertension in Adulthood
TLDR
Childhood hyperuricemia is an independent risk factor of hypertension and is ‘linked to’ adult blood pressure.
Serum Uric Acid as Cardiovascular Disease Marker: Premises and Promises
TLDR
The role of SUA as an independent risk factor for myocardial infarction (MI) and cerebrovascular ischemic stroke (CVIS) has been previously discussed, though this association has been under keen observation in view of conflicting reports.
The uric acid metabolism pathway as a therapeutic target in hyperuricemia related to metabolic syndrome
TLDR
Although UA may have a protective effect due to its antioxidant properties, it is clear that the dominant effect of UA in MS is deleterious and it is extremely important to prescribe drugs which concomitantly decrease hyperuricemia and improve co-morbidities associated with hyperuricaemia.
Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease
TLDR
Xanthine oxidase inhibitor use was associated with reduced risk of cardiovascular disease in patients with cardiovascular risk factors and was evaluated using a time to event analysis.
SERUM URIC ACID LEVELS IN METABOLIC SYNDROME ASSOCIATED WITH DIABETES, HYPERTENSION, CHRONIC KIDNEY DISEASE AND APPARENT HEALTH
TLDR
Serum uric acid may not serve as a good marker for the MS in the study population and it may be due to dietary differences between the reported society and the present study population.
SERUM URIC ACID LEVELS IN METABOLIC SYNDROME ASSOCIATED WITH DIABETES, HYPERTENSION, CHRONIC KIDNEY DISEASE AND APPARENT HEALTH
TLDR
Serum uric acid may not serve as a good marker for the MS in the study population and it may be due to dietary differences between the reported society and the present study population.
Uric Acid as a Mediator of Endothelial Dysfunction in Hypertension
TLDR
It is concluded that high levels of uric acid is a sensitive marker of risk for cardiovascular disease and also suggests that elevated serum uric Acid level is associated with atherogenesis independent from hypertension.
Uric acid, hyperuricemia and vascular diseases.
TLDR
This review takes a brief look at hyperuricemia and its role in neurological diseases, and highlights the studies of the advanced pathological mechanisms of uric acid and inflammation.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 66 REFERENCES
Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.
A role for uric acid in the progression of renal disease.
TLDR
Hyperuricemia accelerates renal progression in the RK model via a mechanism linked to high systemic BP and COX-2-mediated, thromboxane-induced vascular disease and provides direct evidence that uric acid may be a true mediator of renal disease and progression.
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart Study
TLDR
The relation of baseline serum uric acid level to incident coronary heart disease events is described and a growing body of laboratory and clinical evidence suggests that uric Acid plays a role in platelet adhesiveness, formation of free radicals, and oxidative stress.
Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension.
TLDR
Findings support the hypothesis that uric acid has a key role in the pathogenesis of early onset essential hypertension, and may unify some of the disparate theories of the origins of essential hypertension.
Hypouricemia and hyperuricemia in type 2 diabetes: two different phenotypes
TLDR
The relation between uric acid and metabolic parameters, creatinine clearance and albumin excretion rate in a cohort of type 2 diabetic patients is evaluated.
Uric acid and endothelial dysfunction in essential hypertension.
TLDR
The data demonstrate an inverse and significant relationship between UA and ACh-stimulated vasodilation in patients with uncomplicated, untreated essential hypertension, independent of traditional cardiovascular risk factors.
A causal role for uric acid in fructose-induced metabolic syndrome.
TLDR
The first evidence that uric acid may be a cause of metabolic syndrome is provided, possibly due to its ability to inhibit endothelial function, as well as a reduced vasodilatory response of aortic artery rings to acetylcholine.
Elevated Uric Acid Increases Blood Pressure in the Rat by a Novel Crystal-Independent Mechanism
TLDR
Mild hyperuricemia causes hypertension and renal injury in the rat via a crystal-independent mechanism, with stimulation of the renin-angiotensin system and inhibition of neuronal NO synthase.
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
TLDR
Allopurinol therapy significantly decreases serum uric acid levels in hyperuricemic patients with mild to moderate chronic kidney disease and helps preserve kidney function during 12 months of therapy compared with controls.
Resurrection of uric acid as a causal risk factor in essential hypertension.
In his landmark paper describing the entity of essential hypertension, Frederick Akbar Mahomed observed that many hypertensive subjects came from gouty families, leading him to suggest uric acid as a
...
1
2
3
4
5
...